Medical Marijuana, Inc.’s CBD Oil RSHO-X™ Garners National News Coverage Across Mexico After News of Country’s Medical Cannabis Legalization


SAN DIEGO, May 12, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Mexico and its cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-X™) garnered national news headlines across Mexico after news of the Mexican Congress passing legislation April 28 to legalize the use of marijuana and cannabis for medical and scientific needs in Mexico.

An article from Mexico newspaper Reforma “Proyectan oportunidad con mariguana,” or “They project an opportunity with marijuana,” and other news articles from major national Mexico outlets discuss how the therapeutic decriminalization of marijuana in Mexico will enable HempMeds® to reach more patients suffering from debilitating medical conditions.

“We are extremely pleased that the therapeutic benefits of RSHO-X™, including the mention of a recent study by renowned Mexican physician Dr. Saul Garza Morales that found RSHO-X™ to be effective in treating 39 children, have been highlighted in numerous articles discussing the recent cannabis reform in Mexico,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Since becoming the first company to provide Mexico citizens with access to a medical product based on cannabis (THC-free hemp CBD), we’ve been at the forefront of the discussion on cannabis reform in the country and are always thankful when news outlets share the story of HempMeds® and RSHO-X™, because as more news spreads, the more citizens we can help that suffer from debilitating medical conditions.”

Additional coverage from national Mexico outlets include: 

Medical Marijuana, Inc., started exporting to Mexico to help families gain access to THC-free CBD hemp oil RSHO-X™ after the Health Department of Mexico, COFEPRIS, issued the country’s first-ever government permits on February 2, 2016, to two families, including the Maldonado family whose daughter suffered from a severe form of epilepsy.

Medical Marijuana, Inc. created its subsidiary HempMeds® Mexico after RSHO-X™ product became the first and only cannabis product allowed for import into the country. HempMeds® Mexico works side by side with doctors, patients, and policy makers in Mexico to ensure those in need of CBD have access to it.

Follow the link here for more information on HempMeds® Mexico and here for its historic first-year milestones.

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

About HempMeds® 
HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC PINK: MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.

FORWARD-LOOKING DISCLAIMER AND DISCLOSURES
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.  The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.



Source link